PREPRINT (not peer reviewed)

New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: PsyArXiv
Date: 2021-05-05
Source: PsyArXiv
DOI: 10.31234/osf.io/2489x
PubMed: Unavailable

Authors

Forstmann M Sagioglou C.

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Addiction Mechanism of Action Wellbeing Personality Change Creativity Review Article Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding StudyClinicalTrials.gov · 2023-03-20 Double-blind Placebo-controlled Naturalistic Study of Microdosing With Psilocybin: Effects on Brain Activity, Behavior, Cognition, Creativity, and Mental HealthClinicalTrials.gov · 2021-12-16 Serotonergic Psychoactive Compounds as a Treatment for Addiction, Anxiety, and Depression: Their Efficacy and LegalityFurman University Scholar Exchange (Furman University) · 2019-01-01 An Overview on the Taxonomy, Phylogenetics and Ecology of the Psychedelic Genera Psilocybe, Panaeolus, Pluteus and GymnopilusFrontiers in Forests and Global Change · 2022-05-23